drugset / Trial / NCT01028209
Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions
NaSingle-groupOpen-labelDiagnostic
Summary
The underlying goal of this study is to assess \[18F\] PBR06 PET imaging as a tool to detect microglial activation in the brain of Alzheimer Disease (AD), Parkinson Disease (PD) and Multiple Sclerosis (MS) research participants.
Timeline
- Start
- 2009-11
- Primary completion
- 2010-09-22
- Completion
- 2010-09-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [F-18]PBR06 | Diagnostic / imaging agent | 185 mbq | — |